Tian Zhang, MD, of UT Southwestern Medical Center, expands on treatment outcomes for patients with prostate cancer after imaging with Ga68-PSMA-PET.
She details differences in PSA PFS and time to castration resistance between patients with PSMA+/CT-negative and PSMA+/CT-positive prostate cancer on Ga68-PSMA-PET/CT imaging.
Негізгі бет Prostate Cancer Outcomes After Ga68-PSMA-PET Imaging
Пікірлер